Atlas Trials

Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer

Clinical trial NCT02553928 · COMPLETED

Trial details

NCT number
NCT02553928
Sponsor
H. Lundbeck A/S
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Alzheimer Dementia (AD)
Start date
2015-10-01
Primary completion
2016-07-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.